PALO ALTO, Calif. & CAMBRIDGE, England--(BUSINESS WIRE)--Today, Open Monoclonal Technology, Inc. (OMT) and Recombinant Antibody Technology, Ltd (RAT) announced a ...
Antibodies offer several favorable characteristics such as high specificity, minimal off-target effects and good safety profiles. By triggering several immune effector mechanisms, antibodies can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results